ÇÁ·Î±×·¥
½Ã°£ | ÁÖÁ¦ | ¡¡ | ¿¬ÀÚ | ¼Ò¼Ó |
---|---|---|---|---|
08:25~08:30 | Àλ縻 | ´ëÇÑ¿Ü°úÃÊÀ½ÆÄÇÐȸ ȸÀå ¹ÚÀÏ¿µ | ||
08:30~09:00 | Cutting edge technology of medical industry | ÁÂÀå | ¹ÚÇظ° | Â÷ ÀÇ °ú ´ë |
¡¡ |
BARD ALPINION Mammotome ÇÑ¿µ¹«¿ª(HIFU) ½ºÅ¸¸Þµå °æº¸Á¦¾à |
|||
¡¡¡¡ | Session 1. Ç÷°ü ÃÊÀ½ÆÄ | ÁÂÀå | Á¤±¸¿ë | ÀÌ È ÀÇ ´ë |
¹ÚÁ¾±Ç | ÀÎ Á¦ ÀÇ ´ë | |||
09:00~09:20 | Role of USG for diagnosis of diabetic foot angiopathy | ¡¡ | ¹ÚÁ¦ÈÆ | °¡Å縯ÀÇ´ë |
09:20~09:40 | Usefulnes of USG in transplanted organ-liver | ¡¡ | ÃÖÈ£Áß | °¡Å縯ÀÇ´ë |
09:40~10:00 | Usefulness of USG transplanted organ-kidney | ¡¡ | °íÁø | ÀÎ ÇÏ ÀÇ ´ë |
10:00~10:20 | Ultrasound findings of nerves to be careful in varicose vein treatment in legs | ¡¡ | Á¶ÁøÇö | °æ Èñ ÀÇ ´ë |
10:20~10:40 | What parameters should be checked by USG in AVF or AVG surveillance? | ¡¡ | ¾ç½Å¼® | ¿µ ³² ÀÇ ´ë |
10:40~10:50 | Quiz | |||
10:50~11:10 | Coffee Break | |||
¡¡¡¡ | Session 2. ±¸¿¬¹ßÇ¥ | ÁÂÀå | ¹Ú¼øö | °¡Å縯ÀÇ´ë |
±è±¸»ó | ¿ï»êµ¿°º´¿ø | |||
11:10~11:20 | À¯¹æ¾Ï ¼ö¼ú¿¡¼ ¹«¼¼Æ÷ ÁøÇÇ ±âÁúÀÇ À¯¿ë¼º Æò°¡ Usefulness of acellular dermal matrix (Megaderm®) in breast cancer surgery |
ÃÖÇöÁ¤, ½ÅÇõÀç | ÇÑ ¾ç ÀÇ ´ë | |
11:20~11:30 | Á¾¾ç¼ºÇü À¯¹æ¼ö¼ú ÈÄ Áö¹æ±«»çÀÇ ÀÚ¿¬°æ°ú: 10³â ÃßÀû ¿¬±¸ Natural course of fat necrosis after oncoplastic breast surgery: A 10-year follow-up study |
ÀÌ·ù°æ, ¹ÚÈ£¿ë ±è¿Ï¿í, ÀÌÁö¿¬ ¹ÚÂù¼·, ÀÌÁ¤ÁÖ ±ÝÈñÁ¤, ¾çÁ¤´ö ÀÌÁ¤¿ì, ÀÌÁؼ® Á¤ÁøÇâ |
°æºÏÀÇ´ë ¿Ü°úÇб³½Ç ºÐÈ«ºûÀ¸·Î º´¿ø ¿Ü°ú† °æºÏÀÇ´ë ¼ºÇü¿Ü°úÇб³½Ç‡ |
|
11:30~11:40 | ½Ã¾Æ³ë¾ÆÅ©¸±·¹ÀÌÆ®¸¦ ÀÌ¿ëÇÑ Á¤¸Æ·ù Ä¡·á ÈÄ EGITÀÇ ÃÊÀ½ÆÄ Æò°¡ Ultrasound-based evaluation of endovenous glue-induced thrombosis after cyanoacrylate closure of varicose vein |
Á¶ÁøÇö | °æ Èñ ÀÇ ´ë | |
11:40~11:50 | ÇÏÁöÁ¤¸Æ·ù ȯÀÚ¿¡¼ ÃÊÀ½Æĸ¦ ÅëÇÑ °ñ¹Ý ¿øÀÎÀÌ µÇ´Â ÁúȯÀÇ À¯º´·ü The prevalence of pelvic origin in patient with varicose vein by diagnosing ultrasonography |
À¯±Çö | Ãæ ºÏ ÀÇ ´ë | |
11:50~12:00 | Ç÷°ü³» º¹ºÎ´ëµ¿¸Æ·ù Ä¡·á ÈÄ Á¶¿µÁõ° ÃÊÀ½Æİ˻縦 ÀÌ¿ëÇÑ µ¿¸Æ³»´©Ãâ °¨½ÃÀÇ À¯¿ë¼º The Usefulness of Contrast-Enhanced Ultrasound(CEUS) for surveillance of endoleak after Endo-Vascular Aortic Repair(EVAR) |
Á¶½ÃÁø, ±Ç¼ö°æ Á¤´Ù¹Ì, ¹Ú¼øö ±èÀå¿ë, À±»ó¼· |
°¡Å縯ÀÇ´ë |
|
12:00~12:10 | Diagnostic accuracy of Focused Assessment with Sonography For blunt andominal trauma in the Level ¥° trauma Center | Dae Hyun Cho, MD, Dae Sang Lee MD, Maru Kim, MD. PhD, Hang Joo Cho, MD, PhD | °¡Å縯ÀÇ´ë |
|
12:10~12:20 | ÃÑ È¸ | |||
12:20~13:30 | ·±Ãµ ½ÉÆ÷Áö¾ö | ÁÂÀå | ¹èÁ¤¿ø | ½É»çÆò°¡¿ø |
Therapeutic application of VABB for benign breast diseases | Tan Yah Yuen | Mount Elizabeth Medical Center, Singapore |
||
¡¡¡¡ | Session 3. À¯¹æ & °©»ó¼± ÃÊÀ½ÆÄ | ÁÂÀå | ¹ÚÈñºØ | ¹ÚÈñºØ¿Ü°ú |
±è±Çõ | Á¶ ¼± ÀÇ ´ë | |||
13:30~13:50 | Ultrasonographic alterations associated with the dilatation of mammary ducts : feature analysis and BI-RADS assessment | ¡¡ | ±è¹ÎÁ¤ | ¿¬ ¼¼ ÀÇ ´ë ¿µ»óÀÇÇаú |
13:50~14:10 | Breast benign lesion management with VABB(Mammotome) in China | ¡¡ | Zhao Wenhe | Sir Run Run Shaw Hospital of Zhejiang University, China |
14:10~14:30 | Second international consensus conference on lesions of uncertain malignant potential in the breast (B3 lesions) | ¡¡ | ½ÅÀº¾Æ | Â÷ÀǴ뺴¸®°ú |
14:30~14:50 | Ultrasonographic evaluation of the breast implant related complication | ¡¡ | ±è¹Î¼ö | ÇÑ ±¹ À¯ ¹æ º¸Çü¹°¿¬±¸È¸ |
14:50~15:10 | Ultrasonographic differenciation between thyroid and parathyroid nodule | ¡¡ | Á¤¼Ò·É | °¡Å縯ÀÇ´ë |
15:10~15:30 | Thyroid ultrasound reporting of diffuse thyroid diseases | ¡¡ | Á¤ÁøÇâ | °æ ºÏ ÀÇ ´ë |
15:30~15:40 | Quiz | |||
15:40~16:00 | Coffee Break | |||
¡¡¡¡ | Session 4. º¹ºÎ/´ëÀåÇ×¹®/ÁßȯÀÚ ÃÊÀ½ÆÄ | ÁÂÀå | ±èÇüö | ¼øõÇâÀÇ´ë |
Á¶Çö¹Î | ¼ ¿ï ÀÇ ´ë | |||
16:00~16:20 | Application of ultrasound in HBP field | ¡¡ | ÀÌÁؼ | ¼ ¿ï ÀÇ ´ë |
16:20~16:40 | Ultrasound-guide intraoperative radiofrequency ablation for liver tumors | ¡¡ | °í¾ç¼® | Àü ³² ÀÇ ´ë |
16:40~17:00 | Practical use of anorectal ultrasound | ¡¡ | °èºÀÇö | °¡Å縯ÀÇ´ë |
17:00~17:20 | How to approach chest region by ultrasound | ¡¡ | Á¶´ëÇö | °¡Å縯ÀÇ´ë |
17:20~17:40 | Ultrasound guided procedures for surgeons | ¡¡ | ÀÌÀç±æ | ¿¬ ¼¼ ÀÇ ´ë |
17:40~17:50 | Quiz¡¡¡¡¡¡ | |||
17:50~18:00 | Çà¿î±Ç Ãß÷ & Æóȸ»ç |
¡¡Room A | ¡¡Room B | |||||
---|---|---|---|---|---|---|
½Ã°£ | ÁÖÁ¦ | °»ç | ¼Ò¼Ó | ÁÖÁ¦ | °»ç | ¼Ò¼Ó |
9:00~10:30 | Á÷Àå Ç×¹® ÃÊÀ½ÆÄ (5¸í) | ÀÌÀ±¼® | °¡Å縯ÀÇ´ë | Ãæ¼öµ¹±â ÃÊÀ½ÆÄ I (5¸í) | Á¶±ÔÇö | ÇϳªÁ¾ÇÕ³»°ú |
°£´ãÃé ÃÊÀ½ÆÄ I (5¸í) | Á¤ÀçÈ« | ¼øõÇâÀÇ´ë | ||||
10:30~10:50 | coffee break | coffee break | ||||
10:50~12:20 | °£´ãÃé ÃÊÀ½ÆÄ II (5¸í) | ÃÖÈ£Áß | °¡Å縯ÀÇ´ë | Ãæ¼öµ¹±â ÃÊÀ½ÆÄ II (5¸í) | ±è´ëÇö | À̾ر賻°ú |
Áß½ÉÁ¤¸Æ°ü »ðÀÔ¼ú (5¸í) | ±è¹ÌÇü | °¡Å縯ÀÇ´ë | ¿Ü»ó ÃÊÀ½ÆÄ (5¸í) | Á¶Ç×ÁÖ | °¡Å縯ÀÇ´ë | |
12:20~13:30 | Á¡½É | Á¡½É | ||||
13:30~14:30 | ÇÏÁöÁ¤¸Æ·ùÀÇ ÃÊÀ½ÆÄ I (5¸í) | ±è±âÈ | Ǫ ¸§ ¿Ü °ú | °æµ¿¸ÆÃÊÀ½ÆÄ (5¸í) | Á¶ÁøÇö | °æ Èñ ÀÇ ´ë |
14:30~15:30 | ÇÏÁöÁ¤¸Æ·ùÀÇ ÃÊÀ½ÆÄ ¥± (5¸í) | Àü°¿õ | °¡Å縯ÀÇ´ë | ÇÏÁöµ¿¸ÆÀÇ ÃÊÀ½ÆÄ (5¸í) | Á¤ÇõÀç | ¾ç»êºÎ»ê´ëº´¿ø |
15:30~16:00 | coffee break | coffee break | ||||
16:00~17:00 | À¯¹æ ÃÊÀ½ÆÄ I (7¸í) | ÀÌÀº°æ | ºñ¿¡ºñ½º³ª¹«º´¿ø | °©»ó¼± ÃÊÀ½ÆÄ I (7¸í) | Á¤ÁøÇâ | °æ ºÏ ÀÇ ´ë |
À¯¹æ ÃÊÀ½ÆÄ II (7¸í) | À̵¿¼® | ºÐÈ«ºûÀ¸·Îº´¿ø | °©»ó¼± ÃÊÀ½ÆÄ II (7¸í) | È«Àç¿õ | Çöó¿ö¿©¼º¿Ü°ú | |
17:00-18:00 | VABB (Mammotome) (5¸í) | ½ÅÇõÀç | ÇÑ ¾ç ÀÇ ´ë | Thyroid RFA (10¸í) | ¾öÅÂÀÍ | ÇÏÀÌÀ¯¿Ü°ú |
VABB (Encore) (5¸í) | ±èµ¿¿ø | ´ë¸²¼º¸ðº´¿ø | ±è±Çõ | Á¶ ¼± ÀÇ ´ë | ||
VABB (Bexcore) (5¸í) | ¹éÁ¾¹Î | °¡Å縯ÀÇ´ë | Thyroid Core biopsy (10¸í) | °í½Â»ó | ¹ÚÈñºØ¿Ü°ú | |
Breast Core biopsy (5¸í) | ±è±¸»ó | µ¿ ° º´ ¿ø | Thyroid FNA (10¸í) | ±¸º»¿ë | À¯¾ØÀ¯¿Ü°ú | |
¹Ú¹ÎÈ£ | Àü ³² ÀÇ ´ë |
Á¦¸ñ | ÀúÀÚ | ¼Ò¼Ó | |
---|---|---|---|
1 | ¾×¿ÍºÎÀÇ ½ºÆĸ£°¡´®Áõ; Áõ·Êº¸°í Axillary sparganosis; a case report |
ÀÌ°Èñ, ±èÁÖÈï† | ¿¬¼¼ÀÇ´ë ¿Ü°úÇб³½Ç ±¹¹Î°Ç°º¸Çè Àϻ꺴¿ø ¿Ü°ú† |
2 | Success Rate of Bedside PICC with Ultrasound- guided and Characteristics of tip Position in Single Institution | Sang Seob Yun, Soo Mi Son, Da Mi Jung, Soo Kyung Kwon, Jang Yong Kim and Sun Cheol Park | °¡Å縯ÀÇ´ë |
3 | ÁßȯÀÚ¿¡¼ ÃÊÀ½ÆÄ À¯µµÇÏ ¸»ÃÊÁ¤¸Æ»ðÀÔÀÇ ÀÓ»ó¾ç»ó Clinical characteristics of sonoguided Peripherally inserted central catheter in Critically ill patients |
Á¤Ã¢¿¬, ¹èÁ¤¹Î | ¿µ ³² ÀÇ ´ë |